Medical Funds Management Limited

Aggressive Fund

MAS KiwiSaver SchemeAggressive

What the provider says about this fund

The Aggressive Fund invests mainly in growth assets with a small allocation to income assets. The Fund aims to provide higher returns over the long term. It is suitable for investors who are prepared to accept a higher level of investment risk to potentially achieve a higher return.

1-year return

12.18%

5-year return p.a.

6.08%

Total annual fee

0.97%

Fund size ($m)

267.9

Members

3,992

Inception date

1 October 2007

Risk indicator

The official Smart Investor risk indicator uses a scale from 1 to 7.

1
2
3
4
5
6
7
Lower riskHigher risk

Investment mix

Growth assets

93.94%

Income assets

6.06%

Asset classActualTargetAverage for Aggressive funds
Australasian shares29.31%29.00%28.28%
Commodities0.00%0.00%0.09%
International bonds2.33%3.30%0.17%
International shares64.61%66.00%59.89%
Listed property0.00%0.00%8.08%
New Zealand bonds1.71%1.70%0.17%
Unknown0.00%0.00%0.00%
Unlisted property0.00%0.00%0.17%

Top 10 holdings

RankAssetAsset classAsset typeCountry% of fund
1Fisher & Paykel Healthcare LtdSharesAustralasian EquitiesNZ4.85%
2Infratil LtdSharesAustralasian EquitiesNZ3.68%
3Apple IncSharesInternational EquitiesUS2.84%
4Nvidia CorpSharesInternational EquitiesUS2.66%
5Hunter Global Fixed Interest FundBondsInternational Fixed InterestNZ2.33%
6Auckland International Airport LtdSharesAustralasian EquitiesNZ2.25%
7Alphabet Inc Class ASharesInternational EquitiesUS2.16%
8Microsoft CorpSharesInternational EquitiesUS2.10%
9Meridian Energy LimitedSharesAustralasian EquitiesNZ1.88%
10A2 Milk Company LtdSharesAustralasian EquitiesNZ1.87%

Fees

0.97% total annual fee

Fee typeFeeCost per year on a $30,000 balanceAverage for Aggressive funds
Management fees0.87%$2610.71%
Other fees0.10%$300.08%
Membership fees0.00%$00.05%
Total combined fees0.97%$2910.85%

Yearly returns

Year endingFund returnAverage for Aggressive funds
31 March 201712.63%11.18%
31 March 20186.31%6.93%
31 March 20197.12%9.96%
31 March 2020-0.73%-6.59%
31 March 202130.30%35.19%
31 March 20223.77%3.36%
31 March 2023-3.54%-4.50%
31 March 202414.40%16.43%
31 March 20254.58%4.58%
31 March 202612.18%12.72%

Key personnel

NamePositionTime in role
Brendan O’donovanChair Investment Committee8 years, 9 months
Daniel MeadHead of Investment2 years, 8 months
Hayden GriffithsHead of Asset Allocation, JBWere29 years, 11 months
Phil BorkinSenior Strategist, JBWere7 years, 3 months
Rickey WardHead of Investment Strategy & Research, JBWere11 months